PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
08-Jun-2020 Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica
08-Jun-2020 First adjuvanted quadrivalent influenza vaccine receives EU approval Seqirus
08-Jun-2020 Novo Holdings REPAIR Impact Fund Launches Global Call for New Investment Proposals to Fight AMR Novo Holdings
08-Jun-2020 Vectura signs agreement with Aerami Therapeutics Inc Vectura Group plc
08-Jun-2020 Helsinn announces FDA acceptance of IND application for TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities Helsinn Group
05-Jun-2020 Calliditas Therapeutics prices its initial public offering on The Nasdaq Global Select Market in the United States Calliditas Therapeutics AB
05-Jun-2020 Herbert Smith Freehills advises Acacia on its acquisition of shares in up to 19 public and private life sciences companies Herbert Smith Freehills’
05-Jun-2020 Sosei Heptares notes Phase IIIb ARGON study with Enerzair® Breezhaler® (QVM149) meets primary endpoint in patients with uncontrolled asthma Sosei Group Corporation
04-Jun-2020 Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels Hyloris Pharmaceuticals SA
04-Jun-2020 AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”) AMRYT PHARMA PLC
04-Jun-2020 MARINOMED EXPANDS INTO ITALY AND BROADENS ITS PORTFOLIO Marinomed Biotech AG
04-Jun-2020 Chi-Med Announces the Continuation of Phase III FRUTIGA Study of Fruquintinib in Second-Line Gastric Cancer in China Following a Planned Interim Data Review Chi-Med
04-Jun-2020 PureTech Founded Entity Follica Announces Positive Feedback from FDA as it Prepares to Advance its Lead Programme in Male Androgenetic Alopecia into Phase 3 Development PureTech Health
04-Jun-2020 Singapore's LABMED shipped over 20 million masks to meet global demand LABMED
04-Jun-2020 Almac Group Welcomes Confirmation that Northern Ireland’s Pharmaceutical Industry will Maintain Regulatory Alignment with the EU Post-Brexit Almac Group
04-Jun-2020 Celltrion Healthcare showcases positive 1-year data and budget impact analysis for novel subcutaneous formulation of infliximab in patients with rheumatoid arthritis at the European E-Congress of Rheumatology 2020 Celltrion
04-Jun-2020 Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work hVIVO
04-Jun-2020 ENHERTU® (Trastuzumab Deruxtecan) Achieved a Tumour Response Rate of 45.3% (95% CI, 70.2%-91.9%) in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial1 AstraZeneca
03-Jun-2020 Ervaxx rebrands as Enara Bio to reflect a broader emphasis on the discovery and development of novel TCR-based cancer immunotherapies Enara Bio
03-Jun-2020 Oncodesign establishes strategic alliance with HitGen to strengthen its Integrated Drug Discovery Service (IDDS) named DRIVETM Oncodesign